Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1946563 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $1.25Day −16.11%Mkt cap $3M1Y −77.4%Off 52W high −85.5%Vol (1Y) 196.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 761 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest5.5% of sh out |
| Days to cover1.5d |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.0M |
| Earnings (TTM)-$7.6M |
| ROE−196.4% |
| Net margin−732.5% |
| ROIC−814.8% |
| Debt / equity0.04× |
| Sales growth 3Y65.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−38.5% |
| 1Y−77.4% |
| 3Y−99.8% |
| Since incept. (ann.)−89.3% |
Total return through 2026-07-30 · series begins 2023-07-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)196.8% |
| Ann. volatility (3Y)161.4% |
| Sharpe (1Y)−0.09 |
| Sharpe (3Y)−0.60 |
| Max drawdown (1Y)−82.6% |
| Max drawdown (3Y)−99.8% |
| Beta (3Y vs SPY)2.54 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Kathmere Capital Management, LLC | 144,683 | $253,195 | 5.49% | new |
| UBS Group AG | 31,410 | $54,968 | 1.19% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 16,295 | $28,516 | 0.62% | new |
| BARCLAYS PLC | 1,856 | $3,248 | 0.07% | new |
| OSAIC HOLDINGS, INC. | 25 | $43 | 0.00% | new |
| TWIN PEAKS WEALTH ADVISORS, LLC | 8 | $14 | 0.00% | new |
| CITIGROUP INC | 1 | $2 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$1.28 | — | $162,092 | −0.9% |
| 2025-12-31 | 2026-03-30 | — | — | $303,385 | +25.6% |
| 2025-09-30 | 2025-11-13 | — | — | $437,602 | +223.4% |
| 2025-06-30 | 2025-08-13 | — | — | $100,932 | −19.2% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
